NeuroTobe Pharmaceuticals Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
NeuroTobe Pharmaceuticals General Information
Description
Developer of drugs intended for brain disease treatments. The company discovers drugs to cure Parkinson's and dystonia disease.
Contact Information
Website
www.neurotobe.com(Operating Subsidiary)
Corporate Office
- T108, Jinri Hall, 193 Munji-ro
- Yuseong-gu
- Daejeon, 34051
- South Korea
Corporate Office
- T108, Jinri Hall, 193 Munji-ro
- Yuseong-gu
- Daejeon, 34051
- South Korea
NeuroTobe Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
NeuroTobe Pharmaceuticals FAQs
-
When was NeuroTobe Pharmaceuticals founded?
NeuroTobe Pharmaceuticals was founded in 2020.
-
Where is NeuroTobe Pharmaceuticals headquartered?
NeuroTobe Pharmaceuticals is headquartered in Daejeon, South Korea.
-
What industry is NeuroTobe Pharmaceuticals in?
NeuroTobe Pharmaceuticals’s primary industry is Drug Discovery.
-
Is NeuroTobe Pharmaceuticals a private or public company?
NeuroTobe Pharmaceuticals is a Private company.
-
What is the current valuation of NeuroTobe Pharmaceuticals?
The current valuation of NeuroTobe Pharmaceuticals is .
-
What is NeuroTobe Pharmaceuticals’s current revenue?
The current revenue for NeuroTobe Pharmaceuticals is .
-
When was NeuroTobe Pharmaceuticals acquired?
NeuroTobe Pharmaceuticals was acquired on 25-Sep-2024.
-
Who acquired NeuroTobe Pharmaceuticals?
NeuroTobe Pharmaceuticals was acquired by HLB Global.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process